Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Serbia extended its tender for the Galenika AD drug company for a fourth time, giving a unit of Canada’s Valeant Pharmaceuticals International Inc until June 14 to file a bid, the Finance Ministry said on its website. The government first called for bidders on Jan. 15, seeking a partner among drugmakers with operating revenue of at least €200 million ($$259.5 million) in 2011. Galenika cut its 2012 loss to RSD 5.6 billion ($65.2 million) from RSD 13.5 billion a year earlier.